Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yongzhan Pharmaceutical Technology is a contract research and manufacturing organization (CRO/CDMO) based in Shanghai, China, that specializes in the development and production of pharmaceutical intermediates and fine chemicals. The company provides a wide range of services including custom synthesis, process development, and scale-up manufacturing to support the global life sciences industry. With a core focus on small molecule chemistry, Yongzhan offers high-quality building blocks and specialty reagents essential for drug discovery and development. Their technical expertise allows them to handle complex chemical transformations, catering to clients ranging from early-stage biotech startups to established pharmaceutical corporations. The firm is committed to accelerating drug R&D through reliable chemical supply and efficient process optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yongzhan Pharmaceutical Technology.